The Society for RNA Therapeutics (SRT) is a global professional network supporting the translational research and development of RNA therapeutics. SRT develops standards for RNA manufacturing and guidelines for clinical trials, facilitates public-private-regulatory partnerships, provides public and professional education, supports early career development, and advocates for accessible RNA therapeutics for all patients.
SRT membership is open to researchers, clinicians, industry professionals, and trainees working in or entering the RNA therapeutics field. There are two membership categories: Professional membership for established scientists and industry professionals, and Trainee membership for graduate students, postdoctoral fellows, and clinical fellows.
SRT offers two membership categories: Professional membership for established scientists and industry professionals, and Trainee membership for graduate students, postdoctoral fellows, and clinical fellows, which is offered at a reduced rate. Current annual rates are listed on the membership page at https://srnat.org/membership/become-a-member.html.
Members join a global network of RNA scientists and physicians, with real opportunities to work directly with leaders in the field on committees that set the direction of RNA therapeutics. It's a pivotal moment for the RNA field, and SRT members are helping define what comes next. Membership also offers event discounts and dedicated programming for early-career PIs and trainees. See the membership page at https://srnat.org/membership/become-a-member.html for more benefits and committee details.
You can apply for membership directly through the membership application form on the SRT website at https://srnat.org/membership/become-a-member.html.
John P. Cooke, M.D., Ph.D. is the Founder and President of SRT. The leadership team and full Board are listed at https://srnat.org/about/.
The SRT Board of Directors comprises senior RNA scientists and clinicians from institutions including Johns Hopkins University, Houston Methodist, the University of British Columbia, the University of Michigan, Cold Spring Harbor Laboratory, Tel Aviv University, Yale University, City of Hope, Duke University, the University of Pennsylvania, Baylor College of Medicine, Boston Children's Hospital, and the Icahn School of Medicine at Mount Sinai. Board members include Drew Weissman, 2023 Nobel Laureate in Medicine. The full current Board with affiliations is listed at https://srnat.org/about/.
SRT's work runs through four committees. The Governance Committee oversees membership policy, financial stewardship, and officer nominations, and membership on it is by Board invitation. The Outreach Committee expands SRT's reach across institutions, disciplines, and career stages. The Communications Committee develops standards, position papers, and regulatory frameworks, covering Standards and Guidelines, the Regulatory Roadmap, and biomanufacturing of RNA therapeutics. The Education Committee oversees the Annual Meeting Program, Young Investigators initiatives, and the SRT Expert Talk Series.
Current and upcoming events are listed at https://srnat.org/events/srt-events.html, and the Expert Talk Series at https://srnat.org/resources/expert-talk-series.html.
You can reach SRT by email at info@srnat.org or through the contact form at https://srnat.org/about/contact.html.